Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Guangdong Dahuanong Animal Health Buys Majority Stake in Competitor

publication date: Jan 9, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Guangdong Dahuanong Animal Health Products will purchase a 60% stake in Foshan Standard Bio-tech Co., Ltd., a fellow veterinary products company, paying 158 million RMB ($25.4 million). Dahuanong said the acquisition would add products to its portfolio, especially a chicken coccidiosis vaccine. Foshan Standard makes pharmaceutical preparations and feed additives, as does Dahuanong. More details....

Stock Symbol: (SHE: 300186)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners